Areas of Research
- Breast Cancer
- Radiation Oncology
- Prevention and Risk Assessment
- Cancer Treatment-Induced Neurotoxicities
Welcome to the Nead Laboratory. We are a genetic epidemiology group primarily working in the “dry-lab” space to study acquired mutations in normal tissues (e.g. breast and blood) to determine 1) their causes, 2) their consequences, 3) and their actionable implications for cancer prevention and treatment. We utilize existing and lab generated genetic and clinical data implementing cutting edge sequencing and computational approaches. Secondary lab areas of focus include 1) “big data” approaches to study the interplay of cardiovascular disease and cancer, including as it relates to acquired mutations in blood (e.g. clonal hematopoiesis) as well as purely health claims based analyses and 2) cancer therapy induced adverse neurocognitive outcomes.
About Kevin T. Nead, M.D., M.Phil.
Kevin Nead is a physician-scientist in the departments of Epidemiology and Breast Cancer Radiation Oncology. While he spends the majority of his time leading a research group, Dr. Nead is a practicing physician in radiation oncology, treating patients with breast cancer, and is especially devoted to medical resident education.
As a scientist, Dr. Nead uses patient level demographic, clinical, and genetic data to work towards preventing cancer and optimizing cancer care. Dr. Nead is committed to providing outstanding student and trainee mentorship and to advancing the study of cancer through open collaboration.
Funding support for the Nead Laboratory has included the National Cancer Institute, the Cancer Prevention and Research Institute of Texas, the American Society of Clinical Oncology, University of Texas Rising STARs, and the Duncan Family Institute.
Join Our Lab
The Nead Laboratory is committed to providing outstanding training designed to meet your personal goals. Individuals at all levels, from undergraduate students to post-doctoral trainees, are welcome to inquire.
News & Media
Dr. Nead's research has been widely featured in the media including The New York Times, The Wall Street Journal, Forbes, The Washington Post, The Telegraph (UK), Business Insider, Scientific American, The Huffington Post, New York Post, Chicago Tribune, The Guardian, Daily Mail, NPR, CBS Nightly News, The Boston Globe and U.S. News and World Report.